Method for detection of risk of heredital determination of breast cancer based on anamnetic data
RU2628816C1
Method for differential diagnostics of benign, primary and secondary malignant brain tumors
RU2625035C1
Method of predicting recurrent soft tissue sarcomas
RU2619341C1
Method of correcting hormonal state during postcastration syndrom in patients of reproductive age with cervical cancer
RU2624509C1
Method for treatment of inoperable asctic forms of ovarian cancer
RU2626682C1
Method for predicting tumour resistance to tethegeth therapy of cetuximab in patients with plane-cellular language of language and multidisal bottom of the pta
RU2624508C1
Method for remission duration prediction in patients with vulva cancer
RU2623143C1
Method for complex evaluation of polychemotherapy efficiency for patients with recurrent hodgkin's lymphoma
RU2624505C1
Method for prediction of metastases development in patients with gastric cancer
RU2615908C1
Method for murine melanoma lymphatic and hematogenous metastasis b16 simulation for nonlinear white rats
RU2612090C1
Method for treatment of locally spread unresectable esophageal cancer
RU2611899C1
Method of organ preservation treatment of invasive cervical cancer
RU2618162C1
Method of anti-ischemic kidney protection in limb-surgical treatment of patients with local kidney cancer under conditions of warm ischemia
RU2620336C1
Treatment method of chronically non-healing wounds
RU2619340C1
Method for local-distributed colon cancer metastasis
RU2625598C2
Method for treatment of patients with local prostate cancer, belonging to group of high risk of disease progression
RU2618405C1
Method for adjuvant chemotherapy duration determination in case of locally advanced colorectal cancer with metastases in regional lymph nodes after radical surgery
RU2619214C1
METHOD FOR PREDICTION OF MODERATELY DIFFERENTIATED ENDOMETRIOID UTERINE BODY T1N0M0 CARCINOMA COURSE IN CASE OF PRIMARY TUMOUR SIZE WITHIN 1 cm
RU2617204C1
Method for postanesthetic excitation prevention for children with cancer
RU2616532C1
Method for assessment of tumour sensitivity to chemotherapy of patients with locally advanced breast cancer
